VANCOUVER, May 9, 2019 /CNW/ - INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX:
IVITF; FRA: 8IS2) the Company is pleased to announce the
appointment of Trevor Dixon as a
Director and Chief Operating Officer of the Company effective
immediately. Mr. Dixon is the founder, President and Chief
Executive Officer of the Company's wholly owned subsidiary Acreage
Pharms Ltd. ("Acreage Pharms").
"Mr. Dixon brings 35 years of successful business experience to
the leadership team of Invictus," said George E. Kveton, CEO of
Invictus. "Trevor will continue to hold his current positions
within Acreage Pharms," continued Mr. Kveton.
Mr. Dixon stated that, "moving forward, it is my intention to
create synergy with all of the Invictus companies and to continue
to grow and further increase the Company's production and
sales."
Mr. Dixon advised that "Phase I and II at the Acreage Pharms
facilities, located near Edson,
Alberta, are in full production utilizing all eleven
flowering rooms for growing both medical and recreational
cannabis. Acreage Pharms continues to increase its bottled
cannabis oil inventory while it awaits approval of its oil sales
license in accordance with Health Canada's Cannabis Act and
Cannabis Regulations. The Company eagerly awaits Acreage
Pharms entering into production in its Phase III, 90,000 square
foot, state of the art facility when the anticipated license
amendment is awarded by Health Canada, which is expected in the
fall of this year."
Acreage Pharms obtained a Health Canada license to produce, grow
and harvest medical cannabis on March 29,
2017 and received its sales license on May 18, 2018. Acreage Pharms continues to accept
patients and retail orders for cannabis. Effective August 3, 2018, Health Canada amended Acreage
Pharms license to include the production of cannabis oil and
cannabis resin.
On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director
Investor Relations
1-844-800-6086
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of brands. Our integrated sales
approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Acreage Pharms Ltd. has designed and is building the Phase 3,
purpose-built cultivation facility, to meet all European Union Good
Manufacturing Practices to facilitate international medical
cannabis sales.
The Company is targeting 50 percent of its production for
medical cannabis nationally and internationally. For more
information visit www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including that Acreage
Pharms is anticipated to receive approval for from Health Canada to
amend their license to allow for the sale of cannabis oil is a
forward-looking statement and contains forward-looking information.
Generally, forward-looking statements and information can be
identified by the use of forward-looking terminology such as
"intends" or "anticipates", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "should", "would" or "occur". Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release, including that Acreage Pharms application to
Health Canada for an amendment to their license will be successful
and Acreage Pharms will receive approval for from Health Canada to
amend their license to allow for the sale of cannabis oil. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, that Acreage Pharms will not receive approval
for from Health Canada to amend their license to allow for the sale
of cannabis oil. Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
out-look that are incorporated by reference herein, except in
accordance with applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invictus-announces-appointment-of-director-and-chief-operating-officer-300847265.html
SOURCE Invictus MD Strategies
